{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:28:10Z","timestamp":1767018490847,"version":"3.48.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Capital Health Research and Development of Special Fund","award":["No.2022-1-2051"],"award-info":[{"award-number":["No.2022-1-2051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03537-9","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:23:46Z","timestamp":1767018226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel hypoxia\u2013immune biomarkers predict response to neoadjuvant chemotherapy in patients with laryngo-hypopharyngeal cancer"],"prefix":"10.1186","volume":"30","author":[{"given":"Lingwa","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jugao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"3537_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and Neck Cancer. N Engl J Med. 2020;382(1):60\u201372. https:\/\/doi.org\/10.1056\/NEJMra1715715.","journal-title":"N Engl J Med"},{"issue":"1","key":"3537_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12957-020-02095-0","volume":"18","author":"TQ Huang","year":"2020","unstructured":"Huang TQ, Wang R, Fang JG, He SZ, Zhong Q, Hou LZ, et al. Induction chemotherapy for the individualised treatment of hypopharyngeal carcinoma with cervical oesophageal invasion: a retrospective cohort study. World J Surg Oncol. 2020;18(1):330. https:\/\/doi.org\/10.1186\/s12957-020-02095-0.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"3537_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/0194599819846073","volume":"161","author":"J Heukelom","year":"2019","unstructured":"Heukelom J, Navran A, Gouw ZAR, Tesselaar ME, Zuur CL, van Werkhoven E, et al. Organ function preservation failure after (chemo)radiotherapy in head and neck cancer: a retrospective cohort analysis. Otolaryngol Head Neck Surg. 2019;161(2):288\u201396. https:\/\/doi.org\/10.1177\/0194599819846073.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3537_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106371","volume":"140","author":"C Sampieri","year":"2023","unstructured":"Sampieri C, Costantino A, Pirola F, Kim D, Lee K, Kim SH. Neoadjuvant chemotherapy combined with transoral robotic surgery for stage III and IV laryngeal and hypopharyngeal carcinomas. Oral Oncol. 2023;140:106371. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106371.","journal-title":"Oral Oncol"},{"issue":"1","key":"3537_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","volume":"8","author":"SJ Cowman","year":"2022","unstructured":"Cowman SJ, Koh MY. Revisiting the HIF switch in the tumor and its immune microenvironment. Trends Cancer. 2022;8(1):28\u201342. https:\/\/doi.org\/10.1016\/j.trecan.2021.10.004.","journal-title":"Trends Cancer"},{"key":"3537_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3389\/fimmu.2017.01412","volume":"8","author":"C Solinas","year":"2017","unstructured":"Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, et al. Immune checkpoint molecules on tumor-infiltrating lymphocytes and their association with tertiary lymphoid structures in human breast cancer. Front Immunol. 2017;8:1412. https:\/\/doi.org\/10.3389\/fimmu.2017.01412.","journal-title":"Front Immunol"},{"issue":"5","key":"3537_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.it.2023.03.012","volume":"44","author":"KP Burke","year":"2023","unstructured":"Burke KP, Markson SC, Sharpe AH. Tracking tumor-specific CD8+ T cell responses. Trends Immunol. 2023;44(5):326\u20138. https:\/\/doi.org\/10.1016\/j.it.2023.03.012.","journal-title":"Trends Immunol"},{"issue":"4","key":"3537_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00428-022-03446-w17","volume":"482","author":"BM Koomen","year":"2023","unstructured":"Koomen BM, de Boer M, van Dooijeweert C, van Lindert ASR, Deckers IAG, Voorham QJM, et al. Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity. Virchows Arch. 2023;482(4):707\u201320. https:\/\/doi.org\/10.1007\/s00428-022-03446-w17.","journal-title":"Virchows Arch"},{"issue":"18","key":"3537_CR9","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.7150\/thno.77281","volume":"12","author":"Y Liang","year":"2022","unstructured":"Liang Y, Tan Y, Guan B, Guo B, Xia M, Li J, et al. Single-cell atlases link macrophages and CD8+ T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma. Theranostics. 2022;12(18):7745\u201359. https:\/\/doi.org\/10.7150\/thno.77281.","journal-title":"Theranostics"},{"issue":"4","key":"3537_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/0115665232325395241018103006","volume":"25","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang L, Li D, Gou M. Comprehensive analysis and experimental validation of HEPACAM2 as a potential prognosis biomarker and immunotherapy target in colorectal cancer. Curr Gene Ther. 2025;25(4):518\u201331. https:\/\/doi.org\/10.2174\/0115665232325395241018103006.","journal-title":"Curr Gene Ther"},{"issue":"6","key":"3537_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X, et al. Circular RNA hsa_circ_0005939 regulates UHRF1BP1L expression by targeting miR-4693-3p to promote colorectal cancer progression. Protein Peptide Lett. 2024;31(6):437\u201346. https:\/\/doi.org\/10.2174\/0109298665297110240611115010.","journal-title":"Protein Peptide Lett"},{"issue":"5","key":"3537_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/0115665232285216240228071244","volume":"24","author":"X Ding","year":"2024","unstructured":"Ding X, Wan A, Qi X, Jiang K, Liu Z, Chen B. ZNF695, a potential prognostic biomarker, correlates with im mune infiltrates in cervical squamous cell carcinoma and endoce rvical adenocarcinoma: bioinformatic analysis and experimental verification. Curr Gene Ther. 2024;24(5):441\u201352. https:\/\/doi.org\/10.2174\/0115665232285216240228071244.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"3537_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1766","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhou Z, Yang S, Yang H. Modulating hypoxia inducible factor-1 by nanomaterials for effective cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(1):e1766. https:\/\/doi.org\/10.1002\/wnan.1766.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"3","key":"3537_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101017","volume":"14","author":"VL Codony","year":"2021","unstructured":"Codony VL, Tavassoli M. Hypoxia-induced therapy resistance: available hypoxia-targeting strategies and current advances in head and neck cancer. Transl Oncol. 2021;14(3):101017. https:\/\/doi.org\/10.1016\/j.tranon.2021.101017.","journal-title":"Transl Oncol"},{"issue":"2","key":"3537_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/0113892029319425240813074610","volume":"26","author":"F Li","year":"2025","unstructured":"Li F, Yang X, Wang X, Mi J, Mou X, Song L, et al. High-throughput sequencing reveals that BCR and TCR repertoires as potential prognostic biomarkers for pediatric patients with B-ALL. Curr Genomics. 2025;26(2):144\u201359. https:\/\/doi.org\/10.2174\/0113892029319425240813074610.","journal-title":"Curr Genomics"},{"issue":"12","key":"3537_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"3537_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. Ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016."},{"key":"3537_CR18","first-page":"12","volume":"1","author":"R Kolde","year":"2019","unstructured":"Kolde R. pheatmap: Pretty Heatmaps. R package version. 2019;1:12.","journal-title":"R package version"},{"issue":"D1","key":"3537_CR19","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3537_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.123930318","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.123930318.","journal-title":"Genome Res"},{"issue":"3","key":"3537_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innovation"},{"issue":"43","key":"3537_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"D1","key":"3537_CR23","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361. https:\/\/doi.org\/10.1093\/nar\/gkw1092.","journal-title":"Nucleic Acids Res"},{"issue":"2-3","key":"3537_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","volume":"58","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya S, Andorf S, Gomes L, Dunn P, Schaefer H, Pontius J, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2\u20133):234\u20139. https:\/\/doi.org\/10.1007\/s12026-014-8516-1.","journal-title":"Immunol Res"},{"key":"3537_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:1\u20138. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinform"},{"issue":"4","key":"3537_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003.","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003.","journal-title":"Immunity"},{"key":"3537_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-27719","volume":"10","author":"UT Shankavaram","year":"2009","unstructured":"Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, Reinhold WC, et al. CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics. 2009;10:277. https:\/\/doi.org\/10.1186\/1471-2164-10-27719.","journal-title":"BMC Genomics"},{"issue":"14","key":"3537_CR28","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, et al. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012;72(14):3499\u2013511. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1370.","journal-title":"Cancer Res"},{"issue":"1","key":"3537_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"key":"3537_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100787","volume":"59","author":"J Kopecka","year":"2021","unstructured":"Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las Rivas J, et al. Hypoxia as a driver of resistance to immunotherapy. Drug Resist Updat. 2021;59:100787. https:\/\/doi.org\/10.1016\/j.drup.2021.100787.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"3537_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","volume":"11","author":"B C\u00f3zar","year":"2021","unstructured":"C\u00f3zar B, Greppi M, Carpentier S, Narni-Mancinelli E, Chiossone L, Vivier E. Tumor-infiltrating natural killer cells. Cancer Discov. 2021;11(1):34\u201344. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0655.","journal-title":"Cancer Discov"},{"issue":"5","key":"3537_CR32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/cam4.2852","volume":"9","author":"T Enokida","year":"2020","unstructured":"Enokida T, Ogawa T, Homma A, Okami K, Minami S, Nakanome A, et al. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Cancer Med. 2020;9(5):1671\u201382. https:\/\/doi.org\/10.1002\/cam4.2852.","journal-title":"Cancer Med"},{"issue":"7","key":"3537_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/hed.27043","volume":"44","author":"PL Swiecicki","year":"2022","unstructured":"Swiecicki PL, Bellile E, Casper K, Chinn SB, Dragovic AF, Jolly S, et al. Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor. Head Neck. 2022;44(7):1509\u201319. https:\/\/doi.org\/10.1002\/hed.27043.","journal-title":"Head Neck"},{"issue":"1","key":"3537_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13287-021-02231-x","volume":"12","author":"ALV Alves","year":"2021","unstructured":"Alves ALV, Gomes INF, Carloni AC, Rosa MN, da Silva LS, Evangelista AF, et al. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Stem Cell Res Ther. 2021;12(1):206. https:\/\/doi.org\/10.1186\/s13287-021-02231-x.","journal-title":"Stem Cell Res Ther"},{"issue":"21","key":"3537_CR35","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-22-0909","volume":"82","author":"Q Guo","year":"2022","unstructured":"Guo Q, Wang H, Duan J, Luo W, Zhao R, Shen Y, et al. An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer. Cancer Res. 2022;82(21):4001\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0909.","journal-title":"Cancer Res"},{"issue":"4","key":"3537_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.eururo.2022.07.023","volume":"83","author":"A Gil-Jimenez","year":"2023","unstructured":"Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, et al. Assessment of predictive genomic biomarkers for response to cisplatin-based neoadjuvant chemotherapy in bladder cancer. Eur Urol. 2023;83(4):313\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2022.07.023.","journal-title":"Eur Urol"},{"issue":"15","key":"3537_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153726","volume":"14","author":"NH McCabe","year":"2022","unstructured":"McCabe NH, Stevenson L, Scanlon E, Douglas R, Kennedy S, Keminer O, et al. Identification of Src as a therapeutic target in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches. Cancers (Basel). 2022;14(15):3726. https:\/\/doi.org\/10.3390\/cancers14153726.","journal-title":"Cancers (Basel)"},{"issue":"28","key":"3537_CR38","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1038\/s41388-021-01846-x","volume":"40","author":"A Lequeux","year":"2021","unstructured":"Lequeux A, Noman MZ, Xiao M, Van Moer K, Hasmim M, Benoit A, et al. Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy. Oncogene. 2021;40(28):4725\u201335. https:\/\/doi.org\/10.1038\/s41388-021-01846-x.","journal-title":"Oncogene"},{"key":"3537_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.758777","volume":"9","author":"W Ouyang","year":"2022","unstructured":"Ouyang W, Jiang Y, Bu S, Tang T, Huang L, Chen M, et al. A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma. Front Cell Dev Biol. 2022;9:758777. https:\/\/doi.org\/10.3389\/fcell.2021.758777.","journal-title":"Front Cell Dev Biol"},{"key":"3537_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951455","volume":"13","author":"L Luan","year":"2022","unstructured":"Luan L, Dai Y, Shen T, Yang C, Chen Z, Liu S, et al. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Front Immunol. 2022;13:951455. https:\/\/doi.org\/10.3389\/fimmu.2022.951455.","journal-title":"Front Immunol"},{"issue":"17","key":"3537_CR41","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1158\/1078-0432.CCR-18-3314","volume":"25","author":"JM Brooks","year":"2019","unstructured":"Brooks JM, Menezes AN, Ibrahim M, Archer L, Lal N, Bagnall CJ, et al. Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer. Clin Cancer Res. 2019;25(17):5315\u201328. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3314.","journal-title":"Clin Cancer Res"},{"key":"3537_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.961858","volume":"10","author":"H Li","year":"2022","unstructured":"Li H, Wang J, He L, Zhang F, Meng Q, Huang J, et al. Construction of a combined hypoxia and EMT index for head and neck squamous cell carcinoma. Front Cell Dev Biol. 2022;10:961858. https:\/\/doi.org\/10.3389\/fcell.2022.961858.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3537_CR43","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41467-019-11662-3","volume":"10","author":"Y Fang","year":"2019","unstructured":"Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, et al. CD36 inhibits \u03b2-catenin\/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019;10(1):3981. https:\/\/doi.org\/10.1038\/s41467-019-11662-3.","journal-title":"Nat Commun"},{"key":"3537_CR44","doi-asserted-by":"publisher","first-page":"1045995","DOI":"10.3389\/fonc.2022.1045995","volume":"12","author":"A Muendlein","year":"2022","unstructured":"Muendlein A, Severgnini L, Decker T, Heinzle C, Leiherer A, Geiger K, et al. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients. Front Oncol. 2022;12:1045995. https:\/\/doi.org\/10.3389\/fonc.2022.1045995.","journal-title":"Front Oncol"},{"key":"3537_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.virusres.2016.04.00522","volume":"220","author":"D Zhao","year":"2016","unstructured":"Zhao D, Liu S, Sun L, Zhao Z, Liu S, Kuang X, et al. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma. Virus Res. 2016;220:52\u20136. https:\/\/doi.org\/10.1016\/j.virusres.2016.04.00522.","journal-title":"Virus Res"},{"issue":"7","key":"3537_CR46","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/stem.2821","volume":"36","author":"B Zhang","year":"2018","unstructured":"Zhang B, Bie Q, Wu P, Zhang J, You B, Shi H, et al. PGD2\/PTGDR2 signaling restricts the self-renewal and tumorigenesis of gastric cancer. Stem Cells. 2018;36(7):990\u20131003. https:\/\/doi.org\/10.1002\/stem.2821.","journal-title":"Stem Cells"},{"key":"3537_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105409","volume":"145","author":"Y Su","year":"2022","unstructured":"Su Y, Tian X, Gao R, Guo W, Chen C, Chen C, et al. Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis. Comput Biol Med. 2022;145:105409. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105409.","journal-title":"Comput Biol Med"},{"issue":"10","key":"3537_CR48","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/microorganisms8101504","volume":"8","author":"K Misawa","year":"2020","unstructured":"Misawa K, Imai A, Kanazawa T, Mima M, Yamada S, Mochizuki D, et al. G protein-coupled receptor genes, PTGDR1, PTGDR2, and PTGIR, are candidate epigenetic biomarkers and predictors for treated patients with HPV-associated oropharyngeal cancer. Microorganisms. 2020;8(10):1504. https:\/\/doi.org\/10.3390\/microorganisms8101504.","journal-title":"Microorganisms"},{"issue":"1","key":"3537_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-020-02214-1","volume":"18","author":"K Misawa","year":"2020","unstructured":"Misawa K, Mima M, Satoshi Y, Imai A, Mochizuki D, Ishikawa R, et al. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation. J Transl Med. 2020;18(1):31. https:\/\/doi.org\/10.1186\/s12967-020-02214-1.","journal-title":"J Transl Med"},{"key":"3537_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.omto.2021.02.012","volume":"20","author":"L Zhao","year":"2021","unstructured":"Zhao L, Ma S, Wang L, Wang Y, Feng X, Liang D, et al. A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer. Mol Ther Oncolytics. 2021;20:545\u201355. https:\/\/doi.org\/10.1016\/j.omto.2021.02.012.","journal-title":"Mol Ther Oncolytics"},{"issue":"3","key":"3537_CR51","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41418-019-0400-z","volume":"27","author":"YL Yang","year":"2020","unstructured":"Yang YL, Zhang Y, Li DD, Zhang FL, Liu HY, Liao XH, et al. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2. Cell Death Differ. 2020;27(3):1105\u201318. https:\/\/doi.org\/10.1038\/s41418-019-0400-z.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3537_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ijc.2390623","volume":"124","author":"WJ Huang","year":"2009","unstructured":"Huang WJ, Xia LM, Zhu F, Huang B, Zhou C, Zhu HF, et al. Transcriptional upregulation of HSP70-2 by HIF-1 in cancer cells in response to hypoxia. Int J Cancer. 2009;124(2):298\u2013305. https:\/\/doi.org\/10.1002\/ijc.2390623.","journal-title":"Int J Cancer"},{"key":"3537_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jtos.2021.04.010","volume":"21","author":"S Dou","year":"2021","unstructured":"Dou S, Wang Q, Qi X, Zhang B, Jiang H, Chen S, et al. Molecular identity of human limbal heterogeneity involved in corneal homeostasis and privilege. Ocul Surf. 2021;21:206\u201320. https:\/\/doi.org\/10.1016\/j.jtos.2021.04.010.","journal-title":"Ocul Surf"},{"key":"3537_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jtos.2021.03.010","volume":"21","author":"J Collin","year":"2021","unstructured":"Collin J, Queen R, Zerti D, Bojic S, Dorgau B, Moyse N, et al. A single cell atlas of human cornea that defines its development, limbal progenitor cells and their interactions with the immune cells. Ocul Surf. 2021;21:279\u201398. https:\/\/doi.org\/10.1016\/j.jtos.2021.03.010.","journal-title":"Ocul Surf"},{"issue":"3","key":"3537_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.trecan.2016.02.002","volume":"2","author":"Q Xu","year":"2016","unstructured":"Xu Q, Chiao P, Sun Y. Amphiregulin in cancer: new insights for translational medicine. Trends Cancer. 2016;2(3):111\u20133. https:\/\/doi.org\/10.1016\/j.trecan.2016.02.002.","journal-title":"Trends Cancer"},{"issue":"2","key":"3537_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1527497","volume":"8","author":"EC Halvorsen","year":"2018","unstructured":"Halvorsen EC, Franks SE, Wadsworth BJ, Harbourne BT, Cederberg RA, Steer CA, et al. IL-33 increases ST2+ Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner. Oncoimmunology. 2018;8(2):e1527497.","journal-title":"Oncoimmunology"},{"issue":"1","key":"3537_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1908010","volume":"10","author":"YQ Jiang","year":"2021","unstructured":"Jiang YQ, Wang ZX, Zhong M, Shen LJ, Han X, Zou X, et al. Investigating mechanisms of response or resistance to immune checkpoint inhibitors by analyzing cell-cell communications in tumors before and after programmed cell death-1 (PD-1) targeted therapy: an integrative analysis using single-cell RNA and bulk-RNA sequencing data. Oncoimmunology. 2021;10(1):1908010. https:\/\/doi.org\/10.1080\/2162402X.2021.1908010.","journal-title":"Oncoimmunology"},{"issue":"9","key":"3537_CR58","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1073\/pnas.1815126116","volume":"116","author":"SP Kubli","year":"2019","unstructured":"Kubli SP, Bassi C, Roux C, Wakeham A, G\u00f6bl C, Zhou W, et al. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. Proc Natl Acad Sci USA. 2019;116(9):3604\u201313. https:\/\/doi.org\/10.1073\/pnas.1815126116.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03537-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:23:47Z","timestamp":1767018227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03537-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3537"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03537-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical rigor of our study protocol was fully endorsed by the Ethics Committee of Beijing Tongren Hospital, Capital Medical University (protocol code: TREC2022-KY018.R1, approval date: 2022-4-21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all individual participants included in this study. The consent forms explicitly state that participants' data may be used for publication in scientific journals and public presentations. All personally identifiable information has been removed or altered to protect participant confidentiality. This study adheres to the journal\u2019s editorial policies on consent for publication and complies with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1264"}}